Literature DB >> 10790814

Don't keep that ACE (inhibitor) up your sleeve! Is ramipril effective for secondary prevention of cardiovascular disease and stroke?

D C Hammett, J C MacFadyen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10790814      PMCID： PMC2144832     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  5 in total

Review 1.  Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?

Authors:  A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

2.  Preventing heart attack and death in patients with coronary disease.

Authors:  S C Smith; S N Blair; M H Criqui; G F Fletcher; V Fuster; B J Gersh; A M Gotto; K L Gould; P Greenland; S M Grundy
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

Review 3.  Does heart failure confer a hypercoagulable state? Virchow's triad revisited.

Authors:  G Y Lip; C R Gibbs
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

4.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

5.  Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group.

Authors:  R E Goldstein; M Andrews; W J Hall; A J Moss
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.